RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $235,000 | -11.0% | 10,499 | -33.3% | 0.09% | -3.3% |
| Q2 2022 | $264,000 | -43.2% | 15,749 | +1.3% | 0.09% | -36.1% |
| Q1 2022 | $465,000 | -5.3% | 15,549 | -2.8% | 0.14% | +12.5% |
| Q4 2021 | $491,000 | +21.5% | 15,989 | +24.9% | 0.13% | +16.4% |
| Q3 2021 | $404,000 | -7.3% | 12,799 | +7.5% | 0.11% | -10.6% |
| Q2 2021 | $436,000 | +16.3% | 11,909 | +9.8% | 0.12% | +7.0% |
| Q1 2021 | $375,000 | +10.0% | 10,849 | +32.0% | 0.12% | +7.5% |
| Q4 2020 | $341,000 | +18.0% | 8,216 | +20.9% | 0.11% | +0.9% |
| Q3 2020 | $289,000 | – | 6,796 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |